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The major determinants of the variability in pubertal maturation are reported to be genetic
and inherited. Nonetheless, nutritional status contributes significantly to this variability.
Malnutrition delays puberty whereas obesity has been associated to a rise in Idiopathic
Central Precocious Puberty (ICPP) in girls. However, epidemiology data indicate that
contribution of obesity to early puberty varies significantly among ethnic groups, and
that obesity-independent inheritable genetic factors are the strongest predictors of early
puberty in any ethnic group. In fact, two human mutations with confirmed association
to ICPP have been identified in children with no history of obesity. These mutations
are in kisspeptin and kisspeptin receptor, a ligand/receptor pair with a major role on the
onset of puberty and female cyclicity after puberty. Progressive increases in kisspeptin
expression in hypothalamic nuclei known to regulate reproductive function has been
associated to the onset of puberty, and hypothalamic expression of kisspeptin is reported
to be sexually dimorphic in many species, which include humans. The hypothalamus of
females is programmed to express significantly higher levels of kisspeptin than their male
counterparts. Interestingly, incidence of ICPP and delayed puberty in children is markedly
sexually dimorphic, such that ICPP is at least 10-fold more frequent in females, whereas
prevalence of delayed puberty is about 5-fold higher in males. These observations are
consistent with a possible involvement of sexually dimorphic kisspeptin signaling in the
sexual dimorphism of normal puberty and of pubertal disorders in children of all ethnicities.
This review discusses the likelihood of such associations, as well as a potential role of
kisspeptin as the converging target of environmental, metabolic, and hormonal signals,
which would be integrated in order to optimize reproductive function.
Keywords: central precocious puberty, kisspeptin receptor signaling, reproduction, LH surge, sexual differentiation
of the brain
INTRODUCTION
A mystery that still puzzles scientists is what initiates puberty.
The age at onset and duration of pubertal development is
primarily driven by genetics (Palmert and Boepple, 2001;
Palmert and Hirschhorn, 2003; Parent et al., 2003). However,
timing of sexual maturation is influenced by other factors
such as nutrition, environment, and sex (Parent et al., 2003).
This review focuses on the role of the G protein-coupled
kisspeptin receptor—KISS1R/Kiss1r—and its endogenous ligand,
kisspeptin, on the onset of puberty and etiology of pubertal dis-
orders. Potential roles of nutrition and sex on kisspeptin signaling
are also discussed.
The onset of puberty is first detected as an increase
in pulses and frequency of gonadotropin-releasing hormone
(GnRH), which leads to mirroring increases in the secretion of
gonadotropins luteinizing hormone (LH) and follicle-stimulating
hormone (FSH) by the pituitary gland. Failure to increase GnRH
or gonadotropin secretion at puberty is the underlying cause
of idiopathic hypogonadotropic hypogonadism (IHH), which
is characterized by impaired sexual maturation and infertil-
ity (Seminara et al., 1998). Conversely, premature activation
of GnRH secretion leads to idiopathic gonadotropin-dependent
(or central) precocious puberty (ICPP).
Most of the advances into the mechanisms of re-activation of
the hypothalamic-pituitary-gonadal (HPG) or reproductive axis
at puberty have been provided by the characterization of genetic
mutations associated with reproductive disorders in humans. The
majority of mutations studied to date were identified in patients
with IHH, a disorder far less frequent than ICPP. Prevalence of
premature puberty has been predicted to be 0.2% in one pop-
ulation (Teilmann et al., 2005), whereas incidence of IHH is
estimated to be 1–10 cases per 100,000 births (or 0.001–0.01%)
(Seminara et al., 1998). Despite of the higher prevalence and of
an estimated 30% familial cases (de Vries et al., 2004), the first
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genetic mutation associated to ICPP was published just four years
ago, in 2008 (Teles et al., 2008).
Two striking distinctions between ICPP and IHH are the
inheritance mode and the marked sexually dimorphic distribu-
tion of these disorders. The pedigree of families with history of
IHH (with a normal sense of smell) show or suggest an auto-
somal recessive mode of inheritance (Bianco and Kaiser, 2009).
This was confirmed in reported cases, which show that only
individuals carrying the associated mutation in the homozygous
(or compound heterozygous) state exhibit the IHH phenotype,
whereas heterozygous parents and siblings have no obvious repro-
ductive abnormalities (de Roux et al., 2003; Seminara et al., 2003;
Bhagavath et al., 2006; Topaloglu et al., 2006; Bedecarrats and
Kaiser, 2007; Nimri et al., 2011). On the other hand, the pedigree
of families with a history of ICPP indicate an autosomal dominant
mode of transmission (de Vries et al., 2004) that is supported by
two reports of humanmutations with confirmed association with
ICPP, which were identified in the heterozygous state in affected
children (Teles et al., 2008; Silveira et al., 2010). Interestingly,
females are at least ten times more likely to develop prema-
ture puberty than males (de Vries et al., 2004). This likelihood
increases if only idiopathic cases of early puberty are considered
(Teilmann et al., 2005; Teles et al., 2011). Conversely, incidence of
hypogonadism is predicted to be about 5-fold elevated in males
(Sykiotis et al., 2010). Severity of the hypogonadism is also influ-
enced by sex as males quite often exhibit more severe symptoms
than females carrying the same mutation.
SEXUAL MATURATION OF THE BRAIN
Sexual maturation of the brain is driven by exposure to sex
steroids at specific windows of sensitivity during development.
The stage of brain development at the time of exposure appears
to be a critical determinant of brain masculinization or femi-
nization. However, there is species specificity in the timing of
brain sensitivity to these effects. In rodents, brain masculiniza-
tion occurs just before and after birth and is heavily dependent
on local conversion of androgens to estradiol by brain aromatases
(McCarthy, 2008; McCarthy et al., 2009). In contrast, sexual
maturation of the brain in humans and other primates occurs
earlier in development, around mid- to late-gestation. Androgens
(rather than estrogens) are the determinants of brain masculin-
ization in primates, although brain aromatization also plays a
role (Michael et al., 1987; Wallen, 2005). Manipulation of brain
exposure to androgens during certain critical developmental win-
dows may produce subjects with the genitals of one sex but with
behaviors that are typical of the opposite sex (Wallen, 2005).
Accordingly, abnormal prenatal exposure of female embryos to
androgens has been described to result in male-typical behavior
and decreased female-typical behavior in species such as Rhesus
monkeys (Wallen, 2005), guinea pig (Phoenix et al., 1959) and
rats (Simerly, 2002). Interestingly, abnormal exposure of mouse
embryos to sex steroids has been associated to corresponding
abnormalities in the sexual dimorphism of kisspeptin expres-
sion in the hypothalamus (Kauffman et al., 2007a,b; Gonzalez-
Martinez et al., 2008).
Consequences of abnormal exposure of the developing human
brain to sex steroids are evidenced by anomalous puberty,
fertility, sexual behavior and even sexual identity in patients
carrying certain genetic mutations (Deladoey et al., 1999; Cohen-
Bendahan et al., 2005; Lin et al., 2007; Zirilli et al., 2008). A
classical example is the brain masculinization that is consis-
tently reported for girls born with congenital adrenal hyperplasia.
Hyperplastic adrenal glands in affected girls produce excessive
amounts of androgens, which flood the developing brains of
affected females (Cohen-Bendahan et al., 2005). Additionally,
affected girls can develop precocious puberty, an effect also
observed in female rodents exposed to androgen (Witham et al.,
2012). Precocious Puberty may sound inconsistent with mas-
culinization or incomplete feminization of the female brain,
which would rather be expected to cause delayed puberty.
Nonetheless, premature puberty is a common symptom in girls
with a family history of another disorder strongly associated
to female androgenization: polycystic ovary syndrome (PCOS)
(Franceschi et al., 2010). Elevated androgens in these cases could
be contributing to premature puberty by abnormally stimulating
the hypothalamic-pituitary-gonadal (HPG) or reproductive axis.
Incidentally, serum kisspeptin is reported to be elevated in adoles-
cents with PCOS. Also, serum kisspeptin positively correlated to
serum LH and testosterone in affected adolescents, suggesting an
involvement of kisspeptin in the etiology of PCOS in these girls
(Chen et al., 2010b).
Genetic mutations leading to aromatase deficiency are also
reported to cause abnormal sexual maturation of the brain in
humans and in mice (Lin et al., 2007; Bakker et al., 2010). This is
due to insufficient aromatization of androgens to estrogens result-
ing in elevated serum androgens. Among the cases of congenital
aromatase deficiency in humans is the 46XX (female) who exhib-
ited boy-typical behavior and male gender identity from early
age, despite estrogen supplementation started at age 3 to cor-
rect for low bone density and delayed bone age (Lin et al., 2007).
Similar masculinization of the brain is described for female mice
with congenital aromatase insufficiency (Bakker et al., 2010).
Interestingly, deficiencies of sexual differentiation of the brain in
these mice were associated to an absence of sexual dimorphism in
the hypothalamic expression of kisspeptin (Bakker et al., 2010).
SEXUAL DIMORPHISM OF PUBERTY AND OF PUBERTAL
DISORDERS
During pubertal transition to sexual maturity, the reproductive
axis is activated in humans (Delemarre-van de Waal, 2002) and
other non-human primates (Plant et al., 1989). The pubertal rise
in gonadal sex steroids is coordinated with the appearance of sec-
ondary sexual features, which culminates with the attainment of
reproductive competence. The onset of puberty in girls occurs 1–2
years earlier than in boys; menarche happens even earlier than
sexual maturity in boys (Iuliano-Burns et al., 2009). A similar
phenomenum is observed in Rhesus monkeys: menarche occurs
around age 2 years in females, whereas males only reach sexual
maturity during the breeding season of their fourth year of age
(Wilen and Naftolin, 1976; Resko et al., 1982; Mann et al., 1998).
These observations are consistent with sexual dimorphism of the
major drivers of puberty.
Prevalence of pubertal disorders in humans is also sexually
dimorphic: incidence of precocious puberty is disproportionally
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higher in girls when compared to boys (de Vries et al., 2004).
The ratio for idiopathic CPP is estimated to be 15–20 females
for each male with the disorder (Teles et al., 2011). On the
other hand, incidence of IHH is 5-fold elevated in males when
compared to females (Seminara et al., 1998; Sykiotis et al.,
2010).
The basis for the sexually dimorphic presentation of puberty
and pubertal disorders in humans is not known, but the under-
lying mechanisms could involve sexually dimorphic signaling
pathways with a role on GnRH secretion, rather than sexual
dimporhism of GnRH neurons. This would be compatible with
the involvement of KISS1R signaling, which has been shown
to be sexually dimorphic in the hypothalamus of mice (Wray
and Gainer, 1987; Kauffman et al., 2007b), rats (Kauffman
et al., 2007a), and sheep (Schwanzel-Fukuda et al., 1981). On
the other hand, GnRH neurons were not found to be sexu-
ally dimorphic in experimental animals such as rats or guinea
pig (Clarkson and Herbison, 2006; Cheng et al., 2010). While
there are no reports of sexually dimorphic pubertal disorders
on experimental animals, investigation of animal models may
help to elucidate the underlying causes of the dimorphism in
humans, provided that appropriate consideration is given to
species diversity.
Of note, requirement of GnRH neurons for fertility in mice
has been reported to be sexually dimorphic (Herbison et al.,
2008). The majority of GnRH neurons were not essential for
puberty or fertility in male or female mice under ideal con-
ditions (Herbison et al., 2008). Male mice expressing 12% of
total GnRH neurons had normal reproductive function and fer-
tility. Females with 12% of total GnRH neurons had normal
puberty, but subsequently develop infertility due to an inabil-
ity to generate LH surges and ovulate (Herbison et al., 2008).
This demonstrated that females require additional GnRH neu-
rons to be fertile after puberty. Sure enough, females expressing
34% of the GnRH neurons had no fertility or cyclicity problems
later on (Herbison et al., 2008). The excess of GnRH neurons
not required for puberty or fertility in ideal conditions could
be, instead, required to warrant or modulate GnRH pulsatility
in response to environmental, nutrition, stress, lactation or other
cues conveying adverse situations. If this were the case, adaptive
capability of GnRH responsiveness to adversity would be incredi-
bly high, as the majority of GnRH fibers would not be required in
ideal conditions.
IDIOPATHIC CENTRAL PRECOCIOUS PUBERTY (ICPP) FACTS
Gonadotropic-dependent or central precocious puberty (CPP)
is characterized by early activation of the reproductive axis.
This form of precocious puberty is further classified as idio-
pathic (ICPP) after tumors or other anatomical abnormalities
are discarded (Klein, 1999). Thus, ICPP is early puberty of cen-
tral origin with no obvious underlying cause. Dysfunction in
these cases presumably lyes on signaling pathways regulating
GnRH pulsatility, which is unmasked at puberty. Thus, ICPP
cases are particularly interesting to investigate, as uncovering
the underlying deffect may expose yet unkown or underappre-
ciated brain pathways critical for puberty and/or reproductive
competence.
Onset of puberty occurs earlier in girls, who are consider-
ably more likley to develop precocious puberty, and 95% of
girls reported with precocious puberty develop the idiopathic (or
genetic) central form of the disorder (Klein, 1999). This sexual
dimorphism could be associated to sexually dimorphic signals
to puberty. The high rate of familial cases of ICPP emphasizes
the genetic origin of this disorder (Palmert and Boepple, 2001;
Anderson et al., 2003; Palmert andHirschhorn, 2003; Parent et al.,
2003; Prete et al., 2008; Aksglaede et al., 2009; Biro et al., 2010;
Ogden et al., 2012).
Epidemiology studies suggest that age at onset of puberty in
girls is decreasing over the years (Anderson and Must, 2005;
Cesario and Hughes, 2007; Golub et al., 2008; Ahmed et al.,
2009; Rosenfield et al., 2009; Biro et al., 2010; Burt Solorzano
and McCartney, 2010); some propose that this decrease, as well
as an increase in diagnosed cases of CPP in girls, would be asso-
ciated to a cuncurrent rise in childhood obesity (Wattigney et al.,
1999; Kaplowitz et al., 2001; Anderson et al., 2003; Lee et al., 2007;
Kaplowitz, 2008). While there is positive correlation of obesity
with early onset of puberty in some studies, this is not true for
others. An example is a strictly controlled Copenhagen Puberty
Study, in which early puberty remained significant after adjust-
ment for body mass index (BMI) (Aksglaede et al., 2009). Another
example is the study by Prete and cols, in which obesity was not a
significantly contributor to premature puberty in the population
studied (Prete et al., 2008).
The distinct ethnic distribution of ICPP reported in several
studies emphasizes the genetic basis of this disorder. Additionally,
these studies show that contribution of ethnicity to early puberty
is significantly heavier than that of obesity (Anderson et al.,
2003; Rosenfield et al., 2009; Biro et al., 2010; Walvoord, 2010;
Ogden et al., 2012). Among girls of normal BMI, those of African
American descent start puberty earlier than any other ethnicity
(Biro et al., 2008; Rosenfield et al., 2009). Within the same eth-
nicity, a minority of overweight/obese girls develops ICPP: 72%
of African American girls are overweight (BMI >25 and <30) or
obese (BMI>30) but only 23% of these developed ICPP. Similarly,
61% of Hispanic girls are overweight or obese, but only 15%
developed ICPP. Thirty-six percent white girls are overweight
or obese but 10% developed ICPP (Biro et al., 2010; Ogden
et al., 2012). Also, the last US National Health and Nutrition
Evaluation Survey (NHANES) shows a clear contribution of
obesity-independent genetic factors to early puberty (Rosenfield
et al., 2009). This survey shows that obesity accelerates puberty
only in earlymaturating girls, whereas thelarche or pubarche were
not affected by obesity in late maturating girls (Rosenfield et al.,
2009).
Lastly, obesity did not appear to have been a factor in the ICPP
developed by the two children carrying the naturally occurring
genetic mutations in KISS1R (Arg386Pro), which was identi-
fied in a girl (Teles et al., 2008) or in kisspeptin (Pro74Ser),
which was identified in an unrelated toddler boy (Silveira et al.,
2010).
Of note, correlation of obesity with puberty is sexually dimor-
phic as well. Rates of obesity are significantly higher in boys than
in girls of pubertal age (age 6–11) in all ethnicities tested (White,
Hispanic and African American) (Ogden et al., 2012). However,
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obesity in boys is largely associated to an opposed phenotype
of delayed puberty and low testosterone, whereas early sexual
maturation in boys is associated to lower rates of obesity when
compared to later maturing boys (Wang, 2002; Burt Solorzano
and McCartney, 2010; Walvoord, 2010).
NATURALLY OCCURRING GENETIC MUTATIONS IN HUMANS
WITH ICPP
KISSPEPTIN AND KISSPEPTIN RECEPTOR
A role for KISS1R and kisspeptin in the etiology of ICPP was
revealed by the identification of two mutations with confirmed
association to ICPP, one in KISS1R (Arg386Pro) and the other
in kisspeptin (Pro74Ser) (Teles et al., 2008; Silveira et al., 2010).
As opposed to KISS1R mutations associated to IHH; however,
the two affected children carry the associated gain-of-function
mutation in the heterozygous state. This is in conformity with the
autosomal dominant inheritance (one mutated allele is enough
for the manifestation of the phenotype) predicted for famil-
ial ICPP (de Vries et al., 2004). Nonetheless, tests performed
for an additional kisspeptin mutant identified in two unrelated
Brazilian girls (His90Asp) did not detect significant changes in the
activity of the mutant (Silveira et al., 2010). Two additional muta-
tions associated with ICPP in genome-wide association studies
(His196Pro-KISS1R and Pro110Thr-kisspeptin) await confirma-
tion of this association (Luan et al., 2002, 2007).
To date, mutations in KISS1R or kisspeptin appear to account
for a minority of ICPP cases, as the majority of patients inves-
tigated to date have no mutations in the exons or exon-intron
boundaries of KISS1R or KISS1.
MUTATIONS IN OTHER GENES INVESTIGATED IN HUMAN ICPP
Among a plethora of proteins in which genetic mutations could
potentially affect pubertal development, this section focus on
genes that have been investigated in patients with ICPP, which
include TAC3, TACR3, LIN28B, GABRA1, and NPY.
TACR3 and TAC3 genes
The TACR3 encodes the G protein-coupled receptor neurokinin
B (NKR3), and the TAC3 gene encodes neurokinin B (NKB), the
natural ligand for the NKR3. NKB and NKR3 are co-expressed
with kisspeptin in a unique set of neurons named KNDy neu-
rons, which are conserved across mammalian species and have
been described for humans (Hrabovszky et al., 2010), mon-
keys (Ramaswamy et al., 2010), sheep (Goodman et al., 2007),
goat (Wakabayashi et al., 2010), rat (Burke et al., 2006), and
mice (Navarro et al., 2009). Increase in serum gonadotropins in
response to stimulation of KNDy neurons by senktide (an NKB
analog) has been demonstrated in monkeys (Ramaswamy et al.,
2010), rats (Navarro et al., 2011), and ewes (follicular phase only)
(Billings et al., 2010).
Loss-of-function mutations in NKB or in NK3R have recently
implicated this ligand/receptor pair in the etiology of IHH in
humans (Guran et al., 2009; Topaloglu et al., 2009; Fukami et al.,
2010; Gianetti et al., 2010; Young et al., 2010; Francou et al., 2011).
Also, one mutation in NK3R has been identified in a patient with
ICPP (Ala63Pro-NK3R). However, association of this mutation
with ICPP is yet to be confirmed, as the same mutation is present
in the patient’s mother, who reports normal pubertal develop-
ment, and no functional assays have been performed for this
mutation (Tusset, 2010; Teles et al., 2011).
LIN28B
LIN28B is the human homolog of a C. elegans gene with a role
in timing larvae to adult maturation, which suggests that LIN28B
could play a role in human sexual maturation. This is supported
by genome-wide association studies indicating that polymor-
phisms in or near the LIN28B gene could be significant sources of
variation in the age atmenarche in girls (He et al., 2009; Ong et al.,
2009; Perry et al., 2009). One mutation in LIN28B was indentified
in the heterozygous state in a 4 year-old girl with sporadic (not
inherited) ICPP. Nonetheless, functional assays performed did
not detect significant changes in the activity of this mutant (Teles
et al., 2011); thus, significance of LIN28B for human pubertal
maturation remains unknown.
GABRA1
GABRA1 encodes the gamma amino butyric acid A1 receptor α-1
subunit, which is reported to be essential for the effects of the
gamma-aminobutyric acid type A (GABAA) receptors on GnRH
neurons (Lee et al., 2010). An interest in investigating GABAA
receptors in girls with ICPP came from studies showing that
a GABAA receptor antagonist (bicuculine) accelerated puberty
in monkeys (Keen et al., 1999), and that this effect was medi-
ated by kisspeptin as indicated by robust increases in kisspeptin
secretion in response to bicuculine (Kurian et al., 2012). Also,
the effect of bicuculine on GnRH neurons was prevented by
pre-treatment with anti-kisspeptin serum (Terasawa et al., 2010;
Kurian et al., 2012). However, sequencing the GABRA1 gene in a
cohort of girls with ICPP did not detect mutations (Brito et al.,
2006). Additionally, selective reduction of GABAA receptors in
GnRH neurons in mice did not result in visible pubertal abnor-
malities (Lee et al., 2010), suggesting that deficiencies in this
receptor would be compensated for in rodents.
NPY receptor
The NPYR gene encodes the receptor for neuropeptide Y (NPY),
which antagonizes GABA effects on GnRH neurons. This antago-
nism was shown to play a role in pubertal development in mon-
keys and rodents (Terasawa and Fernandez, 2001). Additionally,
hypothalamic NPY-producing neurons were shown to co-express
Kiss1r and respond to kisspeptin in mouse cells and sheep
hypothalamic explants. These observations raised the possibility
that mutations in the NPYR gene could play a role in the etiology
of ICPP (Backholer et al., 2010; Kim et al., 2010). Nonetheless,
sequencing of the NPY receptor-1 detected only a synonymous
(does not result in amino acid substitution) single nucleotide
polymorphism (SNP) in the heterozygous state in a girl with
familial ICPP, and this polymorphism was present at a higher rate
in the control population (28%). Moreover, in vitro assays failed
to show altered activity for this mutant (Freitas et al., 2007).
KISSPEPTIN RECEPTOR SIGNALING AND PUBERTY
The KISS1R was first linked to reproductive function in 2003,
when loss-of-function mutations in this receptor were associated
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to IHH in two unrelated consanguineous families (de Roux et al.,
2003; Seminara et al., 2003). Affected members of both fam-
ilies carried the associated mutation in the homozygous state,
whereas heterozygous siblings and parents had no obvious repro-
ductive abnormalities (de Roux et al., 2003; Seminara et al.,
2003). Additional loss-of-function mutations in KISS1R were
subsequently identified in patients with IHH (de Roux et al.,
2003; Lanfranco et al., 2005; Semple et al., 2005; Pallais et al.,
2006; Tenenbaum-Rakover et al., 2007; Teles et al., 2010; Nimri
et al., 2011). More recently, a loss-of-function mutation in the
kisspeptin gene (KISS1) was also associated to IHH in a con-
sanguineous family with history of IHH (Topaloglu et al., 2012).
Similarly, disruption of Kiss1r or Kiss1 in mice resulted in a phe-
notype compatible with that of IHH in humans (Funes et al.,
2003; Seminara et al., 2003; Dungan et al., 2007; Kauffman
et al., 2007b; Lapatto et al., 2007; Colledge, 2009). Conversely,
kisspeptin treatment was shown to advance puberty in intact
female mice (Navarro et al., 2004b), and two gain-of-function
mutations (one in the KISS1R and the other in the KISS1 gene)
were identified in children with ICPP (Teles et al., 2008; Silveira
et al., 2010). These observations validate the role of KISS1R and
kisspeptin as essential regulators of GnRH secretion and onset of
puberty.
KISSPEPTIN AND GnRH SECRETION
All loss-of-function mutations in KISS1R or KISS1 have been
shown or are predicted to impair G protein signaling by the
KISS1R, which in turn blocks stimulation of GnRH secretion
by this receptor, impairing spontaneous onset of puberty (de
Roux et al., 2003; Lanfranco et al., 2005; Semple et al., 2005;
Pallais et al., 2006; Tenenbaum-Rakover et al., 2007; Teles et al.,
2010; Nimri et al., 2011). On the other hand, kisspeptin expres-
sion was shown to be high and to increase during puberty
in the infundibular nucleus of the medium basal hypothala-
mus (MBH) in male and female Rhesus monkeys (Hrabovszky
et al., 2010). This pubertal increase in kisspeptin is accom-
panied by parallel changes in GnRH pulses, which suggests a
connection between the increase in kisspeptin and the puber-
tal changes in GnRH pulses (Shahab et al., 2005). The MBH
is reported to contain the majority of neuroendocrine GnRH
neurons in primates and in humans (Krey et al., 1975; Plant
et al., 1978; Hrabovszky et al., 2010). Additional reports show
pubertal increases in hypothalamic kisspeptin expression for mice
(Herbison et al., 2010), rats (Navarro et al., 2004a,b), and teleost
fish cobia (Mohamed et al., 2007), which demonstrates phyloge-
netic conservation of the effect of kisspeptin on sexual maturation
across species. Accordingly, kisspeptin has been shown to stimu-
late gonadotropin secretion in humans (Dhillo et al., 2005), sheep
(Messager et al., 2005), pigs (Lents et al., 2008), rats (Matsui et al.,
2004; Navarro et al., 2005; Pheng et al., 2009), mice (Gottsch et al.,
2004), and gilts (Lents et al., 2008). Pubertal increases in Kiss1r
expression in GnRH neurons have also been reported in mice
(Herbison et al., 2010).
The role of kisspeptin signaling on GnRH pulses is emphasized
by the disruptive effect of the infusion of a kisspeptin antago-
nist (peptide 234) on GnRH pulses in Rhesus monkeys as well
as on gonadotropin secretion in the ewe (Millar et al., 2010;
Guerriero et al., 2012). The detection of Kiss1r expression in
GnRH neurons of cichlid fish (Parhar et al., 2004), rats (Irwig
et al., 2004), and mice (Herbison et al., 2010) further supports
a role for kisspeptin/Kiss1r on GnRH secretion, as well as sug-
gest that kisspeptin would activate GnRH secretion by direct bind
to receptors on GnRH neurons. Localization of kisspeptin fibers
in close apposition with GnRH neurons in mice suggests that
Kiss1r would be expressed at both somata and dentrites (Wray
and Gainer, 1987), enabling kisspeptin to activate signaling on
somata and/or dentrites of GnRH neurons in mice. In humans,
kisspeptin-containing axons have been reported to be in contact
with dentrites of GnRH neurons (Hrabovszky et al., 2008).
In rodents, the arcuate and the anteroventral periventricu-
lar (AVPV) nuclei of the hypothalamus are believed to regulate
GnRH pulsatility. The arcuate nucleus is the target of a potent
negative feedback of estrogen on gonadotropin secretion, whereas
the AVPV is the target of positive feedback of estrogen on
gonadotropin secretion (Mayer et al., 2010). Interestingly, vir-
tually all kisspeptin neurons of the AVPV and of the arcuate
nucleus inmice coexpress estrogen receptor-α (ER-α). Disruption
of ER-α on kisspeptin neurons abolishes both negative and pos-
itive effects of estrogen on gonadotropin secretion (Smith et al.,
2005a, 2006b), which suggests that kisspeptin neurons mediate
estrogenic effects on gonadotropin secretion (Smith et al., 2005a,
2006b). This is supported by the absence of estradiol or andro-
gen receptors on GnRH neurons (Herbison and Theodosis, 1992;
Huang and Harlan, 1993). On the other hand, kisspeptin neu-
rons contain ER-α (Smith et al., 2005a,b; Franceschini et al.,
2006), progesterone (Smith et al., 2007) and androgen (Smith
et al., 2005b) receptors, and a slow release of estrogen restraint
on kisspeptin neurons of the arcuate nucleus is reported to
precede the pubertal increase in kisspeptin (Takumi et al.,
2011).
SEXUAL DIMORPHISMOF KISSPEPTIN EXPRESSION AND
ASSOCIATION TO REPRODUCTIVE FUNCTION
Kisspeptin neurons, kisspeptin expression and/or serum
kisspeptin have been consistently shown to be sexually dimorphic
in many species, including humans (Wray and Gainer, 1987;
Kauffman et al., 2007a,b; Homma et al., 2009; Kauffman et al.,
2009; Bakker et al., 2010; Hrabovszky et al., 2010; Jayasena et al.,
2011; Pita et al., 2011a). This dimorphism has been associated
to the onset of puberty and fertility in some species (Wray and
Gainer, 1987; Kauffman et al., 2007a,b; Homma et al., 2009;
Kauffman et al., 2009; Bakker et al., 2010; Hrabovszky et al., 2010;
Jayasena et al., 2011; Pita et al., 2011a). Prenatal exposure to sex
steroids may account for at least part of the sexual dimorphism
in kisspeptin, and lack of kisspeptin dimorphism can lead to
irreversible abnormalities of the sexual behavior in some species
(Kauffman et al., 2007a,b; Gonzalez-Martinez et al., 2008). Also,
circulating kisspeptin has been reported to be sexually dimorphic
in humans, with women having significantly elevated kisspeptin
when compared to men (Wray and Gainer, 1987; Kauffman
et al., 2007a, 2009; Hrabovszky et al., 2010; Pita et al., 2011a,b).
Expression of the kisspeptin receptor has also been reported to
be sexually dimorphic in rats (Navarro et al., 2004a), Rhesus
monkeys (Shahab et al., 2005), and teleost fish cobia (Mohamed
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et al., 2007), which demonstrates phyllogenetic conservation of
this effect as well.
Observations discussed below support an association between
the sexual dimorphism in KISS1R/Kiss1r/kisspeptin and the sex-
ual dimorphism of the onset of puberty and that of pubertal
disorders.
RELEVANCE OF THE SEXUAL DIMORPHISM IN KISSPEPTIN FOR THE
REPRODUCTIVE FUNCTION IN RODENTS
The AVPV, which is implicated in the generation of the LH
surge and ovulation in females (Smith et al., 2005b), has sub-
stantial sexual dimorphism of kisspeptin expression in rodents,
with the male-typical expression pattern been established just
before and after birth (Kauffman et al., 2007b). This corre-
sponds to the timing of brain masculinization reported for mice.
Kisspeptin fibers in the AVPV of sexually mature females is
12-fold elevated in rats (Kauffman et al., 2007a; Bakker et al.,
2010) and ∼15-fold elevated in mice (Wray and Gainer, 1987).
On the other hand, kisspeptin expression in the arcuate nucleus of
mice showed steroid-dependent sexual dimorphism only before
puberty (Kauffman et al., 2009; Kauffman, 2010). After puberty,
hypothalamic kisspeptin expression in both sexes responded
similarly to changes in serum levels of sex steroids caused by
gonadectomy (Kauffman et al., 2009). This juvenile distinction
could be a sign of earlier onset of puberty in female mice,
which would place rodents among species with a sexual dimor-
phism in pubertal development, in which females maturate earlier
than males.
CONSEQUENCES OF LACK OF KISSPEPTIN SEXUAL DIMORPHISM IN
RODENTS
Disruption of the Kiss1r gene leads to loss of the sexual dimor-
phism in kisspeptin expression in the hypothalamus of male and
female mice (Kauffman et al., 2007b). Kiss1r null females fail
to ovulate and are infertile (Chan et al., 2009), whereas signs
of abnormal sexual maturation in null males resemble those of
male mice with aromatase insufficiency (Kauffman et al., 2007b;
Bakker et al., 2010). Incidentally, the lack of brain masculiniza-
tion in male and female mice with aromatase insufficiency has
been attributed to the absence of masculinization of kisspeptin
neurons, as indicated by inverse cFos activation in kisspeptin neu-
rons of males and females in response to urinary odors in affected
mice (Bakker et al., 2010).
Postnatal administration of testosterone rescued male cop-
ulatory behavior in aromatase-insufficient as well as in Kiss1r
null male mice; however, female preference and other kisspeptin-
dependent sexually dimorphic traits could not be recovered
with postnatal sex steroid replacement in either animal model
(Kauffman et al., 2007b; Bakker and Baum, 2008). These observa-
tions suggest that the sexual dimorphism in kisspeptin expression
is critical for typical male/female sexual responses, which in turn
implicates kisspeptin in the mediation of olfactory signals to
reproduction (Bakker et al., 2010).
Abnormal sexual differentiation of the brain has been atribut-
ted to the abnormal sexual dimorphism in kisspeptin expres-
sion in other animal models such as α-fetoprotein-deficient
mice (Gonzalez-Martinez et al., 2008). Placental α-fetoprotein
metabolizes estrogens, which protects developing females from
excessive exposure to maternal estrogens (Bakker et al., 2006).
Masculinization of the female brain in α-fetoprotein-deficient
females has been attributed to the altered sexual dimorphism of
kisspeptin expression in the AVPV of affected females, who are
infertile and incapable of generating LH surges in response to
steroid stimulation (Gonzalez-Martinez et al., 2008). Similarmas-
culinization of the female brain is described for neonatal female
mice abnormally exposed to sex steroids, who exhibit “male-
typical” low kisspeptin expression in the AVPV and an inability to
generate LH surges (Kauffman et al., 2007a). Conversely, castra-
tion of neonatal male mice right after birth prevented brain mas-
culinization. This resulted in males with female-typical kisspeptin
expression in the AVPV, who exhibited an unusual ability of
mounting LH surges in response to steroid stimulation (Homma
et al., 2009).
SERUM KISSPEPTIN AND SEXUAL DIMORPHISM IN HUMANS
Recent studies have investigated expression and/or secretion of
kisspeptin in adults as well as in pubertal children. While not
definitive, the results of these studies consistently show sexually
dimorphic differences in serum levels as well as in the expres-
sion of kisspeptin in humans. In one study, sexually dimorphic
differences were identified in the distribution and number of
immunolabeled kisspeptin in hypothalamic areas relevant for
reproductive function in humans, with females exhibiting heavily
labeled kisspeptin in the infundibulus, whereas very few, if any,
were present in males (Hrabovszky et al., 2010). Brain samples
analyzed in this study were obtained from healthy human subjects
who died of sudden death (Hrabovszky et al., 2010). Results were
confirmed with an additional antibody from a distinct source,
the analysis was blinded, and the age of research subjects did not
influence the results (Hrabovszky et al., 2010). The homogeneity
of the data in the female group was reassuring against the poten-
tial variability of (unknown) sex steroid levels at the time of death
among research subjects. Nonetheless, findings should be con-
firmed in brains from subjects with similar levels of sex steroids
at the time of death.
Although the source of circulating kisspeptins has not
been established, experimental studies show that intra-
venously injected kisspeptins can effectively stimulate GnRH/
gonadotropin/steroid secretion in humans (Dhillo et al., 2005;
George et al., 2011) and animal models such as Rhesus monkeys
(Ramaswamy et al., 2007), rats (Matsui et al., 2004; Pheng et al.,
2009), and mice (Mikkelsen et al., 2009). Systemic injections
of physiologically relevant concentrations of kisspeptin syn-
chronizes LH surge in cycling ewes and induces ovulation in
non-cycling ewes on the anestrous season (Jayasena et al., 2010).
Similarly, kisspeptin injected peripherally to women is capable
of inducing desensitization of the LH response (Jayasena et al.,
2009) as well as of bypassing the suppression of LH in patients
affected with hypothalamic amenorrhea (Caraty et al., 2007).
These observations demonstrate that circulating kisspeptins are
physiologically relevant and likely to play a role in the regulation
of the HPG axis in many species, including humans.
Serum kisspeptin in adult, sexually mature women was signifi-
cantly elevated when compared to adult men of similar age in two
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studies of different populations from distinct ethnic backgrounds
(Pita et al., 2011a,b). This endorses the sexually dimorphic char-
acter of kisspeptin differences, as opposed to other ethnic-specific
genetic factors.
In healthy children, serum kisspeptin is reported to posi-
tively correlate with rises in LH and testosterone during all
stages of puberty in boys (Bano et al., 2009). Likewise, serum
kisspeptin in pubertal girls is reported to positively correlate to
bone age, peak/basal LH, and LH/FSH ratios (Rhie et al., 2011).
Additionally, healthy pubertal girls from an unrelated popula-
tion were reported to have significantly elevated serum kisspeptin
when compared to tanner grade-matched healthy boys, which are,
in average, one year older (Pita et al., 2011a). These observations
endorse serum kisspeptin as faithful indicator of onset and pro-
gression of puberty in healthy children as well as provide support
for the involvement of kisspeptin in the mediation of the onset
and progression of puberty in children.
KISSPEPTIN AS AN INTEGRATOR OF NUTRITIONAL,
HORMONAL, AND OTHER SIGNALS TO PUBERTY—A
HYPOTHESIS FOR THE ETIOLOGY OF ICPP
LEPTIN AS THE MAIN MEDIATOR OF NUTRITIONAL SIGNALS TO
PUBERTY
Fat-produced leptin is regarded as the main mediator of nutri-
tional signals to reproduction. A role for leptin on the onset
of puberty is evident in leptin-deficient ob/ob mice, which have
arrested puberty and infertility (Swerdloff et al., 1976; Batt et al.,
1982). Similar phenotype is observed in humans with con-
genital leptin deficiency, who present with hypogonadotropic
hypogonadism and other symptoms of leptin deficiency such
as hyperphagia and early onset obesity. All abnormalities are at
least partially rescued with leptin supplementation in humans
(Montague et al., 1977; Clement et al., 1998; Kiess et al., 1998;
Strobel et al., 1998; Farooqi et al., 1999, 2002; Ozata et al., 1999;
Gibson et al., 2004; Licinio et al., 2004) and in ob/obmice (Halaas
et al., 1995; Barash et al., 1996; Chehab et al., 1996; Mounzih et al.,
1997; Kiess et al., 1998).
Co-regulation of reproductive function by nutrition is thought
to improve species survival by suppressing reproduction dur-
ing adversities such as negative energy balance. The absence
of leptin in ob/ob mice leads to a genetically induced state of
negative energy balance. A similar state of negative energy bal-
ance is associated with the suppression of serum leptin in intact
humans and experimental animals subjected to fasting (Nagatani
et al., 1998; Licinio et al., 2004; Welt et al., 2004). Negative
energy balance with suppression of serum leptin is also asso-
ciated with loss of body fat due to extreme exercise routines
or eating disorders in humans (Licinio et al., 2004; Welt et al.,
2004). The negative energy balance in these cases is also reversed
with leptin supplementation (Licinio et al., 2004; Welt et al.,
2004).
While there is no doubt that leptin plays a role in the onset
of puberty, current evidence is not enough to define the precise
nature of this effect. Some argue that the initiation of puberty
in humans (Frisch and Revelle, 1970) and rodents (Kennedy and
Mitra, 1963) would require a critical fat mass, and that the result-
ing increase in fat-produced leptin would be the signal to initiate
puberty once this critical fat mass is achieved (Barash et al., 1996;
Chehab et al., 1996). The fact that injection of leptin accelerates
puberty in normal female mice would support the requirement
of a critical fat mass for the onset of puberty (Ahima et al., 1997;
Chehab et al., 1997). However, Cheung and cols (Cheung et al.,
2001) found unchanged pre-pubertal and pubertal serum leptin
in male and female rats, and serum leptin only correlated with
body weight after puberty in all tested animals (Cheung et al.,
2001).
A similar pattern is observed in children. The three largest epi-
demiology studies in children show that leptin levels are similar in
pre-pubertal boys and girls. Sexually dimorphic differences in lep-
tin only appear at later stages of pubertal development, when boys
and girls are at tanner grades 2–5. At the late stages, girls exhibit
elevated serum leptin when compared to boys. This increase in
serum leptin in females could be attributed to the pubertal rise in
circulating estradiol, as clinical data shows that estrogen increases
leptin in women independently of body fat content (Lavoie et al.,
1999). After correction for fat mass, women have higher serum
leptin than men; premenopausal women have higher leptin than
postmenopausal women, and short-term estrogen replacement
increases serum leptin in postmenopausal women independently
of changes in fat mass. This effect is estrogen-specific, as pro-
gesterone replacement did not affect serum leptin (Lavoie et al.,
1999). These observations suggest that the pubertal increase in
leptin could be a consequence (rather than the trigger) of puberty
in healthy children (Blum et al., 1997; Clayton et al., 1997; Ahmed
et al., 1999).
Additional clinical evidence demonstrates that, despite unde-
tectable serum leptin, patients from a family with history of lipoa-
tropic diabetes who have virtually no subcutaneous or visceral fat
have normal sexual maturation and menarche (Andreelli et al.,
2000). Despite severe leptin deficiency, serum gonadotropins,
gonadal steroids, subsequent menstrual cycles, and fertility were
not affected in these patients (Andreelli et al., 2000). These phe-
notypic characteristics are in contradiction to those of patients
homozygous for mutations that inactivate leptin or the leptin
receptor, which develop early onset obesity and IHH. This incon-
sistency exposes a gap in our knowledge of how leptin regulates
energy metabolism and reproductive function. Nonetheless, the
explanation for the inconsistencies may lie in one fundamental
difference: despite suppressed, any endogenous leptin produced
in patients with lipoatropic diabetes is biologically active, whereas
patients with homozygous loss-of-function mutations in leptin
or the leptin receptor are simply incapable of activating leptin
receptor signaling.
KISSPEPTIN AS THE MAIN TARGET OF LEPTIN SIGNALS TO
REPRODUCTIVE FUNCTION
Kisspeptin is a recognized target of leptin (Smith et al., 2006a;
Backholer et al., 2010). In fact, kisspeptin is believed to be the
main mediator of pubertal effects of leptin. Kisspeptin expres-
sion is highly sensitive to variations in serum leptin or in the
nutritional state (Castellano et al., 2005; Smith et al., 2006a;
Luque et al., 2007; Kalamatianos et al., 2008; Roa et al., 2008;
Quennell et al., 2011), which is compatible with the involve-
ment of kisspeptin in the transmission of nutritional signals
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to reproduction. Accordingly, expression of kisspeptin is sup-
pressed in animal models of congenital leptin deficiency or
negative energy balance (Castellano et al., 2005; Luque et al.,
2007; Kalamatianos et al., 2008), and kisspeptin administra-
tion increases gonadotropin secretion in leptin-deficient or fasted
rodents (Navarro et al., 2004b; Castellano et al., 2005; Roa et al.,
2008). In humans, kisspeptin administration has been shown
to counteract the suppression of serum gonadotropins associ-
ated with hypothalamic amenorrhea, a human model of negative
energy balance (Caraty et al., 2007).
Interestingly, the above effects of kisspeptin occur in spite of
the unaltered state of negative energy balance and suppression of
serum leptin, as well as the absence of changes in body weight
or food intake in affected women or experimental animals. This
indicates that kisspeptin is able to bypass the negative state of
energy balance to activate the HPG axis, suggesting that stim-
ulation of the reproductive axis by kisspeptin is downstream of
metabolic signals such as leptin. This is further supported by the
rescue of vaginal opening, serum gonadotropins, and estradiol
in fasted female mice treated with kisspeptin (Castellano et al.,
2005). Moreover, administration of kisspeptin accelerates puberty
in pre-pubertal female rodents despite prior treatment with anti-
leptin antibody or negative state of energy balance due to fasting
or leptin-resistance (Navarro et al., 2004b, 2005; Castellano et al.,
2005).
In rodents, leptin effects on puberty have been presumed to
result from binding of leptin to receptors located in kisspeptin
neurons of the arcuate nucleus. However, a study using mice
with selective ablation of leptin receptors in kisspeptin neurons is
challenging this presumption. Ablated mice had normal pubertal
development and were fertile (Donato et al., 2011). Additionally,
lesions targeting neurons within the hypothalamic ventral pre-
mammillary nucleus (PMV) blocked the progression of puberty
in ob/obmice by exogenous leptin. These observations are against
the requirement of a direct effect of leptin on kisspeptin neurons.
They also suggest that the main target of leptin would not be
kisspeptin neurons of the arcuate nucleus. Instead, reproductive
effects of leptin would be mediated through the PMV (Donato
et al., 2011). These observations challenge our perception of how
leptin stimulates puberty, and suggest an indirect effect of leptin
on kisspeptin, which would be triggered by binding of leptin to
receptors within the PMV (rather than in the arcuate) nucleus.
This is supported by the absence of leptin receptors in the major-
ity of kisspeptin neurons in the arcuate nucleus (Herbison et al.,
2010) as well as by observations that fasting suppresses kisspeptin
expression in the AVPV (which do not express leptin receptors)
but not in the arcuate nucleus in rats (Kalamatianos et al., 2008).
Nonetheless, current experimental and clinical data consistently
point to kisspeptin as (indirect?) mediator of leptin signals to
reproduction.
PROPOSED HYPOTHESIS
The sexual dimorphism in the distribution of kisspeptin neurons,
in kisspeptin expression, and/or serum kisspeptin is proposed
to contribute to the sexual dimorphism in the onset of puberty
reported for humans and experimental animals. Additionally,
the effect of kisspeptin on the onset and progression of puberty
is proposed to depend on the contribution of puberty signals
from nutritional, hormonal, environmental, and other sources,
which would be integrated at the kisspeptin level in order
to customize/optimize reproductive function. Figure 1 shows a
schematic representation of this hypothesis, in which puber-
tal stimuli would converge into kisspeptin neurons to fine-tune
the effect of these on GnRH stimulation by kisspeptin. Figure 1
also shows the proposed effects on girls and boys of progressive
increases in kisspeptin secretion along puberty. A hypotheti-
cally elevated number of kisspeptin fibers is proposed to con-
tribute to the earlier onset of puberty in girls when compared
to age-matched boys. This is also proposed to contribute to the
significantly elevated incidence of CPP in girls.
The above hypothesis is supported by the sexual dimor-
phism in serum kisspeptin reported for pre-pubertal girls (tanner
grade 1), who exhibit elevated serum kisspeptin when com-
pared to age- or tanner grade-matched boys (Pita et al., 2011a).
This sexual dimorphism persists in adulthood and is corrob-
orated by elevated expression of kisspeptin in the hypothala-
mus, which is reported for females of many species, including
humans (Wray and Gainer, 1987; Cheng et al., 2010; Pita et al.,
2011a,b). The sexual dimorphism in kisspeptin could be associ-
ated to the reported sexual dimorphism in gonadotropin secre-
tion in humans. Serum gonadotropins are elevated in healthy,
pre-pubertal girls (tanner grade 1) when compared to age- or
tanner grade-matched boys (Nottelmann et al., 1987). Notably,
boys in tanner grade 1 are in average one year older than tanner
grade-matched girls.
A role for the sexual dimorphism in kisspeptin in the etiology
of ICPP is supported by the elevated serum kisspeptin reported
for girls with ICPP when compared to age-matched healthy girls1
(de Vries et al., 2009; Chen et al., 2010a; Rhie et al., 2011). These
studies selected precocious girls from distinct ethnic backgrounds
presenting with classic idiopathic CPP (advanced bone age and
elevated LH and FSH peak responses) after other known causes
of the disorder were discarded. Serum kisspeptin in precocious
girls positively correlated with peak LH and LH/FSH ratio but
not with BMI (de Vries et al., 2009; Rhie et al., 2011). In one
study, serum kisspeptin in girls with ICPP correlated with uri-
nary levels of monobutyl phthalate, suggesting that acceleration
of puberty induced by this endocrine disruptor could bemediated
by kisspeptin (Chen et al., 2010a).
The involvement of kisspeptin in the etiology of ICPP is also
supported by two mutations with confirmed association to the
disorder, which were identified in kisspeptin (Pro74Ser) or the
KISS1R (Arg386Pro). Of note, both mutations lead to surpris-
inglymodest increases in signaling, and require KISS1R activation
by kisspeptin, which demonstrates that these mutants lack con-
stitutive activation. The small magnitude of the effects of these
mutants is presumed to be the basis for the gain-of-function,
which for both mutants is due to a prolongation of the endogenous
stimulation of KISS1R by kisspeptin (Teles et al., 2008; Silveira
et al., 2010).
1Relevance of serum kisspeptin to reproductive function is discussed in the
second paragraph of section “Consequences of Lack of Kisspeptin Sexual
Dimorphism in Rodents.”
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FIGURE 1 | Kisspeptin, sexual dimorphism, and puberty: Kisspeptin
neurons (KISS-1) in the infundibular nucleus would be regulated by
positive (1) and negative (2) inputs from nutritional, hormonal and
environmental sources. Possible leptin input on kisspeptin neurons is
shown in (1) and (3). Kisspeptin from KISS-1 neurons (4) or the circulation (8)
stimulate GnRH neurons to secrete GnRH (5). The number of KISS-1 neurons
in the infundibulus is reported to be elevated in women (left panel) when
compared to men (right panel). This sexual difference in kisspeptin is proposed
to contribute to earlier onset of puberty in healthy girls when compared to
boys (6), as well as to the higher incidence of idiopathic CPP in girls (7).
FINAL CONSIDERATIONS
Precocious or late puberty have implications for affected chil-
dren, often requiring long-term counseling. Additionally, both
disorders are associated with increased risk of other diseases. Early
puberty is associated to obesity, polycystic ovaries, metabolic syn-
drome (for girls), and a variety of cancers (Deardorff et al., 2005;
Franks, 2008; Golub et al., 2008; Burt Solorzano and McCartney,
2010; Franceschi et al., 2010), whereas late puberty is associated
with metabolic syndrome (for boys), osteoporosis and osteo-
porotic fractures later in life (Finkelstein et al., 1992; Francis,
1999; Golub et al., 2008). New efficient strategies for early detec-
tion and prevention of pubertal disorders and their associated
health risks require the understanding of the pathophysiological
mechanisms underlying normal and abnormal puberty. For that,
the identification and characterization of upstream regulators of
GnRH pulsatility is of upmost importance.
One additional study comparing serum kisspeptin in pre-
pubertal obese, pre-pubertal age-matched (normal), and ICPP
girls found increased serum kisspeptin in the obese but not in
the ICPP group (Pita et al., 2011a). A likely source of discrep-
ancy with results of studies previously discussed here is the high
cut-off peak LH adopted for the selection of the ICPP group: pre-
mature girls with peak LH <7.0 IU/L were excluded, whereas
above studies excluded girls with peak LH <5.0U/L (de Vries
et al., 2009) or did not adopt a LH cut-off value to exclude poten-
tial subjects (Rhie et al., 2011). Incidentally, the girl carrying
the first genetic mutation with confirmed association to ICPP
(Arg386Pro-KISS1R) would have been eliminated from this but
not the other studies, as her peak LH was 6.4 IU/L (Teles et al.,
2008). Additional support against the exclusion of girls with
LH <7.0 IU/L is provided by the six-month follow-up of girls in
the previous studies, which found no differences in kisspeptin or
any other clinical, laboratorial or tanner stage parameters between
ICPP girls with a peak LH >5.0 IU/l and those with a peak
LH <5.0 IU/l (de Vries et al., 2009). Thus, the high LH cut-off
value likely eliminated girls with true ICPP from the study by
Pita and cols.
Further characterization of the complex relationship of repro-
ductive function with energy metabolism may uncover the basis
for inconsistencies such as the opposite effect of obesity on puber-
tal maturation in boys and girls (Wang, 2002; Burt Solorzano
and McCartney, 2010; Walvoord, 2010), and the intriguing cor-
relation of serum leptin with nocturnal but not with diur-
nal gonadotropin secretion in pubertal girls and adult women
(Matkovic et al., 1997; Licinio et al., 1998). Equally intrigu-
ing is the inverse correlation of nocturnal serum leptin with
weight gain in pubertal girls (Matkovic et al., 1997), and the
puzzling phenotype of patients with lipoatropic diabetes, who
have normal puberty despite the undetectable serum leptin.
Investigation of serum kisspeptin during puberty and adult-
hood in these patients may provide mechanistic insights into
phenotypic inconsistencies between these patients and those
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carrying homozygous loss-of-function mutations in leptin or
leptin receptor.
Finally, despite the failure to identify genetic mutations in
receptors for neurotransmitter such as NPY and GABA in ICPP
girls, the possibility of the involvement of these or other recep-
tors and signaling pathways in the etiology of ICPP cannot be
discarded.
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